HALO

Halozyme Therapeutics, Inc. News Headlines

$9.62
*  
0.28
3%
Get HALO Alerts
*Delayed - data as of Dec. 26, 2014  -  Find a broker to begin trading HALO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    HALO Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
US Stocks Poised For Higher Close This Week; Mylan Reportedly Eyes Swedish Rival
4/4/2014 8:10:21 AM - MT Newswires


Stock Futures Edge Higher Even as Payroll Growth Slows, Jobless Rate Flat at 6.7%
4/4/2014 7:50:31 AM - MT Newswires


Pre-Market Most Active for Apr 4, 2014 : MU, BAC, QQQ, SEAS, HALO, WMC, FB, VOD, MYL, ALU, APC, BBL
4/4/2014 7:39:58 AM - NASDAQ.com News


EC Approves Roche/Halozyme's MabThera SC - Analyst Blog
3/31/2014 10:30:01 AM - Zacks.com


Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 Loss
3/31/2014 9:35:05 AM - Benzinga


Notable Two Hundred Day Moving Average Cross - HALO
3/27/2014 12:15:17 PM - BNK Invest


Positive Data on Halozyme Candidate - Analyst Blog
3/26/2014 5:50:01 PM - Zacks.com


Cramer's Lightning Round: Boston Scientific Is Back Among The Majors (3/11/14)
3/12/2014 6:18:00 AM - Seeking Alpha


Following The Smart Money: The Small Cap Biotech Investments Of Randal J. Kirk
3/11/2014 8:30:00 AM - Seeking Alpha


Mid-Afternoon Market Update: Markets Take a Sharp Dip to the Downside, as Traders Take Month-End Profits
2/28/2014 4:00:26 PM - Benzinga


Halozyme's Q4 Loss Wider-Than-Expected - Analyst Blog
2/28/2014 2:43:01 PM - Zacks.com


Cara Therapeutics (CARA) Zooms: Stock Up 12.4% - Tale of the Tape
2/28/2014 9:39:01 AM - Zacks.com


bluebird bio (BLUE) Zooms: Stock Up 7.2% - Tale of the Tape
2/28/2014 8:51:01 AM - Zacks.com


After Hours Most Active for Feb 19, 2014 : BAC, QQQ, C, TSLA, CIG, PBR/A, PBR, SWY, MU, WEN, FB, HALO
2/19/2014 4:40:00 PM - NASDAQ.com News


Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst
2/19/2014 7:55:00 AM - Seeking Alpha


Baker Brothers' Holding Cerus Flying Under The Radar With Catalyst Upcoming
2/11/2014 8:31:00 AM - Seeking Alpha


Halozyme: Financing PEGPH20 Is Worth Raising Money
2/6/2014 8:41:00 AM - Seeking Alpha


Pre-Market Most Active for Feb 5, 2014 : NOK, HALO, BAC, SAN, JCP, XIV, LPL, TVIX, QQQ, VALE, FB, INTC
2/5/2014 8:39:56 AM - NASDAQ.com News


Does Accuray's Recent Unusual Bullish Options Activity Signal A Rally In The Stock Soon?
1/28/2014 7:50:00 AM - Seeking Alpha


Good News for Halozyme - Analyst Blog
1/27/2014 6:10:01 PM - Zacks.com


Sell Watch: Zeltiq Has Become Over-Speculated
1/21/2014 9:20:00 AM - Seeking Alpha


Forecasting Earnings Growth And Profitability In The Biopharmaceutical Industry
1/21/2014 7:19:00 AM - Seeking Alpha


Pipeline Updates from Halozyme Therapeutics - Analyst Blog
1/14/2014 5:50:01 PM - Zacks.com


BioPharma Catalyst And Investment Pick In Focus: Synergy Pharma
1/2/2014 8:15:00 AM - Seeking Alpha


Is There Still Room To Profit With Halozyme?
12/27/2013 12:52:00 PM - Seeking Alpha